Neo Modulus was jointly founded in March 2017 by a team of Chinese and German scientists led by candidates of the National Major Talent Program. It is an innovative enterprise for R&D, production and commercialization of regenerative implantable medical devices. 
Neo Modulus specializes in production and preparation technology, developing a series of nanoscale stents for tissue engineering, inducing targeted differentiation and growth of cells for unleashing the potential of human regeneration. We are striving to achieve complex tissue regeneration and organ reconstruction while creating comprehensive stores for all our tissue engineering and regenerative medicine (TERM) needs, covering sales, spare parts, services and surveying. 
The company currently has four R&D and production bases in Suzhou, Weifang, Taicang and Shanghai, as well as its overseas laboratory in Freiburg, Germany. The total area of clean room facilities built exceeds 30,000 m2. The company has successively introduced technology from scientific research institutes such as the University of Freiburg, Donghua University and Shanghai Institute of Ceramics, CAS. It has a range of more than 20 implantable medical device products for periodontal soft tissue augmentation and cartilage tissue regeneration. Our product line covers electrospinning, 3D printing, chemical synthesis, physical construction, extraction and purification, as well as tissue engineering on a global scale including decellularization, covering products like membranes, artificial bone, adhesives and microspheres, and extending into oral medicine, ophthalmology, ENT, sports medicine and other clinical fields. 
In the future, Neo Modulus will continue to practice the concept of modular product innovation, strengthen cooperation with well-known research institutions at home and abroad, and develop a greater number of superior products as it realizes its mission of " Decoding regeneration  Safeguarding human health."